Acurx Pharmaceuticals, Inc. (ACXP) vs Alzamend Neuro, Inc. (ALZN)
- Acurx Pharmaceuticals, Inc. ACXP 1.10 −5.98%
- Alzamend Neuro, Inc. ALZN 1.32 +3.13%
Acurx Pharmaceuticals, Inc. and Alzamend Neuro, Inc. are both Biotechnology companies. Acurx Pharmaceuticals, Inc. and Alzamend Neuro, Inc. are of similar size ($6.5M and $6.2M). Across the 9 metrics below, Alzamend Neuro, Inc. leads on 5 and Acurx Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | ACXP | ALZN | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (128.11%) | (163.23%) | (56.36%) |
| Return on assets | (87.57%) | (122.36%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack